INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

74,063 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise · 10b5-1 plan
M—
4,400 sh
Oct 17, 2026Oct 20, 2026
Page 251 of 1852
← PrevNext →
traded Oct 17, 2026
+3d
SEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
5,572 sh
Oct 20, 2026Oct 20, 2026
traded Oct 20, 2026
+0dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Other acquisition or disposition · 10b5-1 plan
J—
5,572 sh
Oct 20, 2026Oct 20, 2026
traded Oct 20, 2026
+0dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Other acquisition or disposition · 10b5-1 plan
J—
2,724 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

56
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market purchase
BUY$2,186
23 sh
Jul 8, 2026Oct 19, 2026
traded Jul 8, 2026
+103dSEC Form 4

Evidence

52
Jonathan L. JacksonDJoint
WMTWalmart Inc.
Sale
SELL$50K – $100KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHouse PTR

Evidence

49
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Open-market purchase
BUY$11.50M
718.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

42
ZG
Zhang Jason GechenPresident
APLDApplied Digital Corp.
Open-market purchase
BUY$5.66M
300.0K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

41
Michael A. RulliRSelf
GOOGAlphabet Inc.
Sale
SELL$50K – $100KOct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dHouse PTR

Evidence

36
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market sale
SELL$1,905
23 sh
Apr 22, 2026Oct 19, 2026
traded Apr 22, 2026
+180dSEC Form 4

Evidence

35
PS
Purcell Lynn SebastianDirector, 10% Owner
CNXUConexeu Sciences Inc.
Open-market purchase
BUY$500K
166.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

35
RV
Radakovich Lynn VojvodichDirector
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$381K
16.8K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

34
Jonathan L. JacksonDJoint
DDOGDatadog, Inc.
Purchase
BUY$50K – $100KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHouse PTR

Evidence

34
Jonathan L. JacksonDJoint
ELESTEE LAUDER COMPANIES INC
Purchase
BUY$50K – $100KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHouse PTR

Evidence

33
PS
Purcell Lynn SebastianDirector, 10% Owner
CNXUConexeu Sciences Inc.
Open-market purchase
BUY—
166.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

33
CP
Carlson Michael PaulGENERAL COUNSEL & SECRETARY
NONENONESterling Real Estate Trust
Open-market purchase
BUY$2,000
78 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

32
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market sale
SELL$11K
108 sh
Aug 24, 2026Oct 19, 2026
traded Aug 24, 2026
+56dSEC Form 4

Evidence

31
BM
Buckley MerileeCHIEF ACCOUNTING OFFICER
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$457K
5,076 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$841K
4,200 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$697K
3,500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$312K
1,600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$470K
2,400 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$535K
2,700 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

28
Jonathan L. JacksonDJoint
GHGuardant Health, Inc.
Purchase
BUY$15K – $50KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHouse PTR

Evidence

28
RV
Radakovich Lynn VojvodichDirector
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
3,500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

27
AJ
Aballi JohnDirector, President and CEO
XGNEXAGEN INC.
Open-market sale
SELL$270K
34.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

26
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$116K
600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

26
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$177K
900 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

26
JD
Jedda DanCFO & COO
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.07M
7,000 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

26
Jonathan L. JacksonDJoint
VSATVIASAT INC
Sale
SELL$50K – $100KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHouse PTR

Evidence

26
KP
Kirol Charles PeterChief Operating Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale
SELL$154K
28.8K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

25
MR
McCrystle Kevin RossDirector, CEO
GRSDGRANDSTAND Ltd
Open-market purchase
BUY$3,365
2,901 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

25
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market purchase
BUY$9,756
108 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

25
BL
Borck LeonDirector
EQBKEQUITY BANCSHARES INC
Open-market purchase
BUY$19K
380 sh
Oct 19, 2026Oct 19, 2026
traded Oct 19, 2026
+0dSEC Form 4

Evidence

24
Jonathan L. JacksonDSpouse
TYGTORTOISE ENERGY INFRASTRUCTURE CORP
Sale
SELL$1,001 – $15KSep 4, 2026Oct 19, 2026
traded Sep 4, 2026
+45dHouse PTR

Evidence

23
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M$310K
16.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

23
HA
How AntoinetteChief Accounting Officer
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
20.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

23
GD
Gus DanielGeneral Counsel & Secretary
EBFENNIS, INC.
Option exercise
M$45K
2,603 sh
Oct 6, 2026Oct 19, 2026
traded Oct 6, 2026
+13dSEC Form 4

Evidence

23
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$20K
100 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

22
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$291K
62.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence